Clinical Trials Browser

Prostatic Hyperplasia, Prostatic Neoplasms

NCT06511141 2026-05-12

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Phase NA Recruiting

150 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder, Overactive

NCT03354416 2026-04-29

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Recruiting

10,000 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT07555756 2026-04-29

An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models

Phase NA Not yet recruiting

1,080 enrolled

Genitourinary

Urinary Bladder Neoplasms, Kidney Calculi, Prostatic Hyperplasia

NCT06161506 2026-04-15

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Phase 2 Recruiting

41 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Incontinence, Urinary Incontinence, Stress, Urinary Incontinence, Urge

NCT07526675 2026-04-13

Bioblation

Phase NA Not yet recruiting

30 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT07510685 2026-04-03

IRIS

Phase NA Completed

240 enrolled

Genitourinary

Urinary Bladder Neoplasms, Prostatic Hyperplasia, Catheter-Related Infections

NCT06834152 2026-02-09

X-SMILE

Recruiting

75 enrolled

Genitourinary

Adenocarcinoma, Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT06051942 2026-01-28

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Phase NA Active not recruiting

125 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT05148156 2026-01-27

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Phase NA Suspended

20 enrolled

Genitourinary

Prostatic Hyperplasia, Nocturia, Dysuria

NCT07238959 2025-11-20

Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer

Not yet recruiting

1,100 enrolled

Genitourinary

Disease, Prostatic Hyperplasia, Prostatic Neoplasms

NCT07071207 2025-11-06

TextMsgM-ISI

Phase NA Recruiting

132 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Incontinence, Stress

NCT04272216 2025-09-09

RAVI Registry

Completed

99 enrolled 15 charts

Genitourinary

Arteriovenous Malformations, Leiomyoma, Prostatic Hyperplasia

NCT06589154 2025-09-02

The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

Completed

1,651 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT07115992 2025-08-26

PRESEL

Phase NA Recruiting

270 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT05768776 2025-06-25

MOSES

Active not recruiting

200 enrolled

EndocrineGenitourinary

Prostatic Hyperplasia, Multiple Endocrine Neoplasia Type 1

NCT04853914 2025-06-05

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.

Phase NA Completed

9 enrolled

Genitourinary

Adenoma, Prostatic Hyperplasia

Clinical Trials

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Bioblation

IRIS

X-SMILE

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer

TextMsgM-ISI

RAVI Registry

The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

PRESEL

MOSES

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.